Latest news

  • European approval for new drug against highly resistant TB

    Monday 3 August

    The European Commission has given conditional market authorisation for the three-drug, six-month, all-oral regimen for the treatment of highly resistant tuberculosis (TB). KNCV Tuberculosis Foundation was closely involved in the […]

    Read more
  • Mustapha Gidado new Executive Director of KNCV

    Thursday 30 July

    Dr. Mustapha Gidado is taking office as the new Executive Director of KNCV Tuberculosis Foundation. He succeeds Kitty van Weezenbeek, who transferred to the World Health Organization (WHO) on May […]

    Read more
  • Summary to the KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers

    Wednesday 22 July

    On Thursday 16th of July 2020 KNCV held its next webinar in the KNCV Webinar Series: ‘Contact Investigation for COVID-19: Lessons from TB Control Programs’. During this webinar we heard […]

    Read more
  • KNCV takes over TIME implementation

    Thursday 16 July

    KNCV Tuberculosis Foundation is taking over implementation of the TIME modelling framework from the London School of Hygiene and Tropical Medicine (LSHTM). TIME is a comprehensive and flexible modelling framework […]

    Read more
  • Summary & video of the KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs – Part 2

    Monday 13 July

    On 2 July 2020 KNCV held its third webinar in the KNCV Webinar Series: ‘Contact Investigation for COVID-19: Lessons from TB Control Programs – Part 2′. If you missed our […]

    Read more
  • KNCV partners with MSH for Eliminate TB from Ethiopia (ETBE) Project

    Monday 13 July

    The US Agency for International Development (USAID) has granted the Eliminate TB from Ethiopia (ETBE) Project. Management Sciences for Health (MSH) will be in the lead of this five year […]

    Read more
  • Summary to the KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs

    Friday 3 July

    On 25 June 2020 KNCV held its second webinar in the KNCV Webinar Series: ‘Contact Investigation for COVID-19: Lessons from TB Control Programs’. If you missed our webinar but would […]

    Read more
  • Summary and link to the KNCV Webinar ‘Infection prevention and control for COVID-19’

    Thursday 25 June

    On 18 June 2020 KNCV kicked off the new KNCV Webinar Series starting with the topic ‘Infection prevention and control for COVID-19 and other acute respiratory infection’. If you missed […]

    Read more
  • Looking back at five successful years of Challenge TB

    Thursday 28 May

    The KNCV-led, USAID-funded Challenge TB (CTB) project operated from 2014 to 2019 in 24 countries and two regions. The overall purpose of CTB was supporting countries with high burdens of […]

    Read more
  • Executive Director Kitty van Weezenbeek leaves KNCV

    Thursday 28 May

    Kitty van Weezenbeek has said goodbye as executive director of KNCV Tuberculosis Foundation. After having held this position for seven years, she continues her impressive career as Director of Surveillance, […]

    Read more
  • KNCV Tuberculosis Foundation sounds the alarm: COVID-19 will cause even more TB deaths

    Thursday 14 May

    The coronavirus has grabbed the attention of the world. Yet with 4,000 deaths a day worldwide, tuberculosis (TB) is holding the macabre top position as the world’s most deadly treatable […]

    Read more
  • Martin Boeree has been appointed professor

    Friday 8 May

    Effective 1 April 2020, Martin Boeree has been appointed professor of Clinical Tuberculosis and other Mycobacterial Diseases at Radboud University/Radboud university medical center. He is the first professor in this […]

    Read more